Clinical use

HYALOFAST® is clinically used for the treatment of symptomatic or asymptomatic chondral or osteochondral defects of the knee:

 ICRS grade III and IV;
 single or multiple;

 which may be caused by:

  • acute trauma,
  • repeated micro-trauma,
  • instability and/or malalignment (in association with reconstructive and/or corrective surgery),
  • Osteochondritis Dissecans (OCD);
 localized on: femoral condyles, trochlea, tibial plateau and patella;
 patients age: 15–55 (but depending on the biological age of the joint);
patients BMI < 35.

HYALOFAST® use is not suggested in cases of:

 osteoarthritic conditions;
 kissing lesions;
 immune system disorders;
 neoplastic diseases;
 metabolic disorders;